Esketamine (Spravato)
Approved + off-label ketamineEsketamine is approved; ketamine is used off-label in clinics across the country.
Last updated 18 August 2026
Psychedelic Therapy Legal Landscape
Esketamine is approved; ketamine is used off-label in clinics across the country.
Off-label medical use in clinics plus approved esketamine.
Since January 2022, physicians can request psilocybin for individual patients with serious or life-threatening conditions through Health Canada’s Special Access Program; s.56 exemptions are a parallel route, and Alberta built the first provincial regulatory framework for psychedelic-assisted therapy (2023).
Same SAP mechanism — physician-initiated, case-by-case.
Medical since 2001, full adult legalization since October 2018 (Cannabis Act) — the most complete framework of any G7 country.
Active research scene alongside the SAP — university hospitals in Toronto, Vancouver and Montreal. Participation is free; screening is strict; never pay for “trial access”.